Keyphrases
Add-on Therapy
24%
Addiction
24%
Adjusted Odds Ratio
47%
Anxiety Level
16%
Cataplexy
18%
Chronic Pain
46%
Chronic Pain Patients
100%
Clinical Impact
24%
Comorbid
24%
Confidence Interval
38%
Dehydroepiandrosterone
73%
Depression Level
32%
Depression Severity
27%
DNA Methylation (DNAm)
16%
DNA Methylation Profile
16%
DNA Methylation Signature
24%
Dual Diagnosis
48%
Familiarity Level
24%
Immigrants
24%
Involuntary Admission
24%
Israel
30%
Medical Marijuana
48%
Medicinal Cannabis
24%
Migrant Patients
24%
Narcolepsy
24%
Negative Symptoms
18%
Non-migrants
24%
Odds Ratio
24%
Opioid Maintenance Treatment
24%
Opioid Misuse
29%
Opioids
26%
Pain Severity
24%
Patients with Schizophrenia
24%
Polydrug
24%
Polysubstance Use Disorder
24%
Positive Symptoms
18%
Prescription Opioid Misuse
24%
Prescription Opioids
73%
Problematic Use
24%
Psychiatric Treatment
24%
Psychiatric Ward
24%
Psychotic States
24%
Schizophrenia
24%
Sectional Analysis
24%
Social Phobia
24%
Specialist Physicians
24%
Symptom Scale
18%
T Cells
24%
Treatment Implications
30%
White Matter Integrity
24%
Neuroscience
Analeptic
6%
Antipsychotic
12%
Anxiety Disorder
9%
Auditory Hallucination
6%
Cannabis
73%
Cataplexy
24%
Corpus Callosum
6%
Decision-Making
24%
Dehydroepiandrosterone
73%
DNA Methylation
24%
DnaA
24%
Drug Therapy
9%
Generalized Anxiety Disorder
18%
Glutamate Decarboxylase
30%
Hypnagogic Hallucination
6%
Loss of Muscle Tone
6%
Mental Disorder
12%
Methylphenidate
6%
Modafinil
6%
Narcolepsy
24%
Negative Syndrome
14%
Paroxetine
6%
Placebo
13%
Positive Syndrome
14%
Psychostimulant
6%
Risperidone
12%
Selective Serotonin Reuptake Inhibitor
6%
Severe Depression
27%
Sleep Paralysis
6%
Social Anxiety Disorder
24%
Somnolence
12%
T Cell
24%